Prevalence
Causes
Clinical
features
Differential
diagnosis
Investigations
Therapy
Prevention
Prognosis
|  |  | | Prognosis |
Patients are at increased risk of dying with
-
an enlarged heart (increased left end-diastolic volume
a
or an enlarged cardiothoracic ratio)
a
-
reduced heart rate variability a
-
reduced or worsening ejection fraction
b
Why?
Cardiac enlargement increases the risk of dying
| Patient |
Prognostic Factor |
Outcome |
CER |
RR (95% CI) |
NNF+
(95% CI) |
severe heart failure b
|
increased left ventricular end-diastolic diameter (by 12 mm)
independent
|
death
at 15 months
|
12%
|
1.69 (1.18 to 2.44) |
12
(6 to 45)
|
|
|
increased cardiothoracic ratio (by 6.5%)
independent
|
|
|
1.62 (1.23 to 2.14) |
13
(7 to 35)
|
Why?
A falling ejection fraction increases the risk of dying
| Patient |
Prognostic Factor |
Outcome |
CER |
OR (95% CI) |
NNF+
(95% CI) |
heart failure b
|
ejection fraction per 10% decrease
independent
|
death
at 12 months
|
24%
|
1.45 (1.39 to 1.50) |
14 (12 to 16)
|
|